LLY · Eli Lilly GP
last $1,164.86-1.57%volume $31.02Mmarket cap n/afeed alpacaas of 2026-09-25 15:30
one year · daily closes52-week high $1,280.5652-week low $713.871m -4.0%3m +5.0%1y +59.5%
FA · financials · ELI LILLY AND COMPANY from the company's own filingsEDGAR ↗
| quarter ending | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| revenue | $22.97B | $19.80B | $19.29B | $17.60B | $15.56B | $12.73B | $13.53B | $11.44B |
| net income | $7.09B | $7.40B | $6.64B | $5.58B | $5.66B | $2.76B | $4.41B | $970.30M |
| EPS (diluted) | 7.94 | 8.26 | 7.39 | 6.21 | 6.29 | 3.06 | 4.88 | 1.07 |
| operating cash flow | $10.69B | $5.33B | $3.22B | $8.84B | $3.09B | $1.67B | $2.47B | $3.71B |
total assets $142.28B (2026-06-30)cash $8.95B (2026-06-30)long term debt $47.86B (2026-06-30)equity $33.88B (2026-06-30)shares outstanding 941,357,065 (2026-08-03)
quarterly figures as filed (10-Q / 10-K); where a company reports year-to-date, the quarter is the difference. No estimates.
news · LLYmore →
headlines and links only; the story is at its outlet